Lifeboat Foundation

Today, we’re offering another talk from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

In her talk, Morgan Levine of the Yale School of Medicine discussed epigenetic biomarkers in detail, discussing the ways in which co-methylation networks provide insight into senescent cells and other facets of biological age.

In the 50 years since the moon landing, humanity has made tremendous leaps in technology. But how close are we to turning our sci-fi aspirations—from space colonies to asteroid mining—into reality? (Partner content)

As the little structures grow, their constituents specialize into different types of brain cells, begin to form connections and emit brain waves. They could be useful models for development and neurological conditions.

Full Transcript

It’s not easy to study the early development of the human brain.

Bitcoin and cryptocurrency adoption has failed to live up to expectations over recent years and fears around scams, fraud, and theft have not helped.

The bitcoin price, after its epic 2017 bull run, slumped last year– though has rebounded in 2019, climbing back above $10,000 per bitcoin.

Now, researchers have warned a staggering four out of the first five results returned when asking Google for a “bitcoin qr generator” led to scam websites–potentially furthering negative public perception around bitcoin and cryptocurrency.

I’m excited to share my new article for The New York Times on the brave new world of #cyborg ability and coming #transhumanism sports:

I wonder whether the sporting industry might create some new competitions where — just like technology — performance-enhancing drugs are encouraged. Innovations like the new oxygen-infused injection, which might one day allow humans to hold their breath for 15 to 30 minutes, could allow competitive free divers to reach new depths, showing just how far the human body can go.

Critics will complain that the human body was not designed to compete using enhancements and that it violates the code given to us by the ancient Greeks and their first Olympics Games, where “arête,” or excellence and moral virtue, was cherished. As a longtime competitive athlete, I appreciate the sportsmanship angle; but I also think that in the 21st century we can develop both the drugs and the technology to see humans compete in new sporting events that are even more exciting than their predecessors.

Continue reading “The Brave New World of Sports” »

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

Today, we’re releasing a talk from Dr. Doug Ethell, who announced his company’s efforts to combat Alzheimer’s disease, describing where and how this neurodegenerative disease starts and discussing his company’s work on developing therapies for the cribiform plate, which naturally clears amyloid-forming proteins from the brain before they aggregate.

IBM HR Director Diane Gherson says that over the next three years, 120 million workers will need retraining as artificial intelligence continues to take jobs.

Artificial intelligence is obviously ready to get started. Over the next three years, about 120 million workers from the 12 largest economies in the world may need to undergo retraining due to advances in artificial intelligence and intelligent automation, according to a study published on Friday by the IBM Institute of Business Value. However, less than half of the CEOs surveyed by IBM said they had the resources needed to bridge the skills gap caused by these new technologies.

Continue reading “Over Next Three Years, Employees will Need Reskilling as AI Takes Jobs” »